Abstract:ABSTRACT Previous studies have shown that the gut microbiota and its metabolites are associated with the success of organ transplantation. However, the specific changes in the gut microbiota of lung transplant patients remain unclear. Hence, this study aimed to elucidate the interplay between the gut microbiota, metabolome, and lung transplantation outcomes. Using 16S metagenomics sequencing and untargeted metabolic profiling, we conducted a comprehensive analysis of gut microbial and metabolic alterations in lung transplant recipients relative to non-transplant group. Our findings revealed the predominance of Enterococcus and Streptococcus genera within the lung transplant cohort, accompanied by the significant reduction in Bacteroides , Epulopiscium , Faecalibacterium , and Prevotella abundance. In addition, a significant reduction in ATRA (all-trans retinoic acid) levels and suppression of IgA production were observed in lung transplant recipients, which were found to be closely associated with the Enterococcus genus. It was speculated that the association might have implications for the prognosis of lung transplant patients. Notably, the differences in gut microbial composition and metabolomic profiles between successful transplant recipients and those experiencing chronic rejection were not statistically significant. These novel insights shed light on the putative implications of the gut microbiota and metabolome in shaping lung transplantation outcomes, and provide a foundation for future investigations and targeted therapeutic interventions. IMPORTANCE This study has profound implications for lung transplantation as it uncovers the important role of gut microbiota and metabolome in shaping transplantation outcomes. The identification of dominant bacterial genera, such as Enterococcus and Streptococcus , within the lung transplant cohort, along with the significant decrease in Bacteroides , Epulopiscium , Faecalibacterium , and Prevotella abundance, reveals potential microbial imbalances associated with lung transplantation. In addition, a significant reduction in ATRA (all-trans retinoic acid) levels and suppression of IgA production were observed in lung transplant recipients, which were found to be closely associated with the Enterococcus genus. It was speculated that the association might have implications for the prognosis of lung transplant patients. These findings hold immense clinical significance as they lay the groundwork for future research and targeted therapeutic interventions. Understanding the impact of the gut microbiota and metabolome on lung transplantation outcomes offers promising avenues for improving transplantation patient prognosis.

Gut microbiota alterations associated with antibody-mediated rejection after kidney transplantation

Unraveling Intestinal Microbial Shifts in ESRD and Kidney Transplantation: Implications for Disease-Related Dysbiosis

Distinct Changes in Gut Microbiota of Patients With Kidney Graft Rejection

The Alteration human of gut microbiota and metabolites before and after renal transplantation

Gut microbiome alterations precede graft rejection in kidney transplantation patients

Intestinal microbiota links to allograft stability after lung transplantation: a prospective cohort study

Structural Shifts of Fecal Microbial Communities in Rats with Acute Rejection after Liver Transplantation

Association of gut microbiota with allograft injury in kidney transplant recipients: a comparative profiling through 16S metagenomics and quantitative PCR

[Gut Microbiota in Renal Transplant Recipients, Patients with Chronic Kidney Disease and Healthy Subjects].

Preliminary Investigation of the Biomarkers of Acute Renal Transplant Rejection Using Integrated Proteomics Studies, Gene Expression Omnibus Datasets, and RNA Sequencing.

Analysis on the change of gut microbiota and metabolome in lung transplant patients

Gut microbiota alterations in renal transplant recipients and the risk of urinary tract infection and delayed graft function: A preliminary prospective study

Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

Antibiotic subclasses differentially perturb the gut microbiota in kidney transplant recipients

Gut Microbiota and Its Implications in Small Bowel Transplantation

Associations Between Gut Microbial Features and Sickness Symptoms in Kidney Transplant Recipients

P8.063: Single-Cell Analysis Reveals Immune Landscape in Kidney Transplant Recipients with Antibody-Mediated Rejection

Intestinal Microbial Variation May Predict Early Acute Rejection after Liver Transplantation in Rats.

Assessing the Relationship Between Gut Microbiota and Posttransplant Diabetes Mellitus.

Unraveling interindividual differences and functional consequences of gut microbial metabolism of immunosuppressants

Longitudinal Lower Airway Microbial Signatures of Acute Cellular Rejection in Lung Transplantation